What’s new at CRO

Date
Jun 23, 2018

MAD/Phase IIa T2D study publication available

Teaser text
As of today you can access a new paper published in The Lancet on 22 June 2018 on a combined multiple-ascending dose (MAD) and Phase IIa study in n=112 patients with controlled type 2 diabetes (HbA1c levels between 6.5–8.5%) via...
Date
Jan 31, 2018

Relocation of Charité Research Organisation's Phase I Unit

Teaser text
In January 2018 CRO’s Phase I unit moved from Campus Virchow-Klinikum (CVK) to Campus Mitte at Charité – Universitätsmedizin Berlin. Located at the very heart of Charité’s historic campus, the new facilities underwent extensive modernisation ...
Date
Nov 28, 2017

Phase IIa Sjögren Syndrome Case Study available

Teaser text
As of today you can access our first case study that illustrates how - with our help - you can reach Proof of Concept faster. This particular case study deals with a  Phase IIa, single dose, double-blind, placebo-controlled, parallel study to assess the PD, PK ...